Third Member of FDA Advisory Panel Resigns Amid Backlash Over Controversial Drug Approval
(childrenshealthdefense.org)
You're viewing a single comment thread. View all comments, or full comment thread.
Comments (5)
sorted by:
How can the FDA approve a drug that hasn't even been proven to be effective yet?
For all we know, this new Alzheimer's drug could be a $65,000 per year placebo.
Graphene is expensive.